Letztes Feedback

Meta





 

Crown Equity Holdings Inc., Added Medical Marijuana Site To Its CRWE-PR Network

http://pennyomega.com/img/crwe_logo.jpg

Las Vegas, NV, April 14, 2013 - (CRWE Press Release) - Crown Equity Holdings Inc. (OTCQB:CRWE) has announced that its CRWE-PR network is in the process of building an online medical marijuana informational and directory search platform. (http://medicalmarijuana.crwe-pr.com) The purpose of the site is to connect people with information in reference to the industry and patients to a network of physicians, dispensaries and more in reference to States with approved Medical Marijuana usage.

The addition of having CRWE-PR’s online medical marijuana news, information and directory is based on the momentum the industry has taken in positioning itself for additional grow in the future.

"Remember; in spite of medical marijuana use being legal in many states, as well as being recreational legal in Colorado and Washington; it is still deemed illegal on the Federal level." stated Kenneth Bosket, President, "Therefore, the information, directory and news is primarily being provided for areas with legalized medical use of marijuana, while adding additional value to the CRWE-PR network." Mr. Bosket added.

About Crown Equity Holdings Inc.

Together with its digital network of websites, Crown Equity Holdings Inc., offers advertising branding and marketing services as a worldwide online multi-media publisher. The company focuses on the distribution of information for the purpose of bringing together its targeted audience and the advertisers that want to reach them. Its advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness. The company launches, invests and manages select businesses, projects and real estate endeavors. For more information regarding Crown Equity Holdings Inc., please visit: http://www.crownequityholdings.com/.

This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new business opportunities and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Contact
Kenneth Bosket, President
702 448-1543

SOURCE: Crown Equity Holdings Inc.

14.4.14 15:57, kommentieren

Werbung


Crown Equity Holdings Inc., Reaches Milestone of 400 Community Websites for the State of California

http://pennyomega.com/img/crwe_logo.jpg

Las Vegas, NV, April 11, 2014 - (CRWE Press Release) - Crown Equity Holdings Inc. (OTCMKTS:CRWE) has announced that its CRWE-PR network of community targeted news, information and business directory publications, have achieved a milestone of creating 400 community based targeted website publications within the State of California. The CRWE-PR network (http://crwe-pr.com) has also completed sites for communities within Northern and Southern Nevada, as well as 9 provinces in Canada.

The CRWE-PR’s mobile marketing platform includes a coupon page for added readership and businesses value. The network offers business owners the power of consumer targeting advertisement on a local and national scale through offerings and deals with their restaurant, auto repair, realtor, bar, movie theater, retail business, golf course, auto dealership and any other variety of businesses existing within a community.

Each community publication is searchable by name or zip code, and will consist of localized Real Estate, Hotels, Classified, City Data, News, Travel, Airlines and Business Listings pages for information. Readers and/or businesses can also create blogs for themselves in any CRWE-PR selected city publication.

"We started building the network in January of 2014." said Kenneth Bosket, President of Crown Equity Holdings Inc. "The development and growth of our CRWE-PR network combined with the approaching implementation of its marketing strategy, allows the company the ability to monetize it." Mr. Bosket added.

The company is also preparing to keep building and strengthen the CRWE-PR network brand for readers and business owners, with additional localized news and informational targeted website publications for communities within the State of New York.

http://pennyomega.com/img/crweapr11.jpg

About Crown Equity Holdings Inc.

Together with its digital network of websites, Crown Equity Holdings Inc., provides and offers advertising branding, marketing solutions and services to boost customer awareness, as well as merchant visibility as a worldwide online multi-media publisher. The company focuses on the distribution of information for the purpose of bringing together its targeted audience and the advertisers that want to reach them. Its advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness. The company launches, invests and manages select businesses, projects and real estate endeavors. For more information regarding Crown Equity Holdings Inc., please visit: http://www.crownequityholdings.com.

This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new business opportunities and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Contact
Kenneth Bosket, President
702 448-1543

SOURCE: Crown Equity Holdings Inc.

11.4.14 16:47, kommentieren

BofI Holding (BOFI) Surges on Acquisition Deal, Crown Equity Holdings (CRWE) on Network Expansion an

http://pennyomega.com/img/penny_omega_logo.jpg

chartstockalert

http://pennyomega.com/img/bofi.jpg BofI Holding, Inc. (BOFI)

BOFI reported that its subsidiary BofI Federal Bank has entered into a definitive purchase and assumption agreement to purchase certain assets and assume all of the deposits of H&R Block Bank. The agreement is subject to regulatory approvals and other customary closing conditions.

In addition, the parties have agreed to terms of a program management agreement under which BOFI's BofI Federal Bank will provide H&R Block-branded financial services products: Emerald Prepaid MasterCard(R), Refund Transfers and Emerald Advance(R) lines of credit through H&R Block's retail and digital channels.

BOFI expects the ongoing annual revenue from the H&R Block program management agreement to be approximately $26 to $28 million starting in fiscal 2015.

BOFI was upgraded from Market Perform to Outperform, with a price target of $100.00 per share by brokerage firm Keefe Bruyette.

http://pennyomega.com/img/bofi2.png



BOFI is the holding company for BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small-to-medium size businesses in target sectors, and selected specialty finance receivables.

More about BofI Holding, Inc. (BOFI) at www.bofiholding.com

**

http://pennyomega.com/img/crwe_logo.jpg Crown Equity Holdings Inc. (CRWE)

CRWE reported that its CRWE-PR network of community targeted news, information and business directory publications, has achieved a milestone of creating 400 community based targeted website publications within the State of California. The CRWE-PR network (www.crwe-pr.com) has also completed sites for communities within Northern and Southern Nevada, as well as 9 provinces in Canada.

The CRWE-PR’s mobile marketing platform includes a coupon page for added readership and businesses value. The network offers business owners the power of consumer targeting advertisement on a local and national scale through offerings and deals with their restaurant, auto repair, realtor, bar, movie theater, retail business, golf course, auto dealership and any other variety of businesses existing within a community.

Each community publication is searchable by name or zip code, and will consist of localized Real Estate, Hotels, Classified, City Data, News, Travel, Airlines and Business Listings pages for information. Readers and/or businesses can also create blogs for themselves in any CRWE-PR selected city publication.

CRWE is also preparing to keep building and strengthen the CRWE-PR network brand for readers and business owners, with additional localized news and informational targeted website publications for communities within the State of New York.

The CRWE Network's business model is based on selling advertising to local businesses.

http://pennyomega.com/img/crweapr11.jpg

CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet.

More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com

**

http://pennyomega.com/img/icld.jpg InterCloud Systems, Inc. (ICLD)

ICLD reported that it was awarded two new major design contracts for small cell deployment.

The first contract is with a national DAS/small cell vendor to provide comprehensive professional small cell deployment and managed services to support their client's network in a major U.S. Theme Park. The second contract is with an OEM to provide communications design services for a major northeast metropolitan city's transit system.

These new contracts are valued at over $600,000 and expand on ICLD's already comprehensive DAS design portfolio which includes many high profile venues.

http://pennyomega.com/img/icldap11.png

ICLD is a global single-source provider of value-added IT services for both corporate enterprises and service providers.

More about InterCloud Systems, Inc. (ICLD) at www.intercloudsys.com.

**

Read Full Disclaimer at www.pennyomega.com/disclaimer

11.4.14 16:23, kommentieren

AVEO Pharmaceuticals (AVEO) Biodesix to Fund Proof of Concept Trial, AngioDynamics (ANGO) Solid Resu

http://pennyomega.com/img/penny_omega_logo.jpg

chartstockalert

http://pennyomega.com/img/aveo.jpg AVEO Pharmaceuticals, Inc. (AVEO)

Your lungs are 2 sponge-like organs found in your chest that supplies the body with oxygen, and removes carbon dioxide from the body.

Lung cancer is the uncontrolled growth of abnormal cells in one or both lungs. These abnormal cells do not carry out the functions of normal lung cells and do not develop into healthy lung tissue. As they grow, the abnormal cells can form tumors and interfere with the functioning of the lung, which provides oxygen to the body via the blood.

Lung cancer is the leading cause of cancer-related mortality in the United States. According to the National Cancer Institute, estimated new cases and deaths from lung cancer in the U.S. in 2014 are:

- New cases: 224,210

- Deaths: 159,260

There are 2 major types of lung cancer: small cell lung cancer and non-small cell lung cancer (NSCLC). About 85% to 90% of lung cancers are non-small cell lung cancer.

AVEO and Biodesix, Inc. reported that they have entered into a worldwide agreement to develop and commercialize AVEO’s hepatocyte growth factor (HGF) inhibitory antibody ficlatuzumab, with a Biodesix(R) companion diagnostic test.

This agreement and the clinical development program will leverage VeriStrat(R), a serum protein test that is commercially available to help physicians guide treatment decisions for patients with advanced non-small cell lung cancer (NSCLC). VeriStrat is based on Biodesix’ proprietary proteomics platform which enables the discovery of multivariate classifiers that characterize a patient’s condition or likely outcome in response to therapy.

Under the terms of the agreement, AVEO will conduct a proof of concept study of ficlatuzumab in combination with erlotinib in advanced NSCLC patients selected using the VeriStrat test. Biodesix will fund up to $15 million of the cost of the study.

Subject to regulatory approval, AVEO will lead worldwide commercialization of ficlatuzumab, while Biodesix will be responsible for all development, including FDA engagement activities, sales and marketing costs for VeriStrat, and will retain total revenues for sales of VeriStrat.

http://pennyomega.com/img/aveochart.png

AVEO is a biopharmaceutical company committed to discovering and developing targeted therapies designed to provide substantial impact in the lives of people with cancer by addressing unmet medical needs.

More about AVEO Pharmaceuticals, Inc. (AVEO) at www.aveooncology.com.

**

 

http://pennyomega.com/img/crwe_logo.jpg Crown Equity Holdings Inc. (CRWE)

CRWE is currently developing its CRWE Network (CRWE-PR.com), a social networking service compatible with both, the mobile and desktop web platform, that is designed to target all the communities in the U.S. and Canada.

Update: The CRWE Network, which business model is based on selling advertising to local businesses, has reached the 393th community website in the U.S., associated with 1736 ZIP Codes, and includes coverage of the greater state of California, Northern and Southern Nevada, Wellington in Florida and 9 provinces in Canada

http://crwe-pr.com/wp-content/uploads/2013/12/CRWE_Network.jpg

CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet.

More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com

**

http://pennyomega.com/img/ango2.jpg AngioDynamics Inc. (ANGO)

Keep a close eye on ANGO. The company reported strong top line performance on its financial results.

For the third quarter fiscal 2014, ANGO posted net sales of $88.2 million, an 8% increase year over year, and net income of $5.1 million, or $0.14 per share, compared to a net loss of $1 million, or $0.03 per share, in the same period the prior year.

ANGO is raising its fiscal year 2014 sales guidance to a range of $351 million to $355 million and anticipates revenue to range from $91 million to $95 million in the fiscal fourth quarter, up to 6% at the top end and 8% on an average daily sales basis, and adjusted EPS without amortization is expected to be in the range of $0.18-$0.21

http://pennyomega.com/img/ango_chart.png

ANGO is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology.

More about AngioDynamics Inc. (ANGO) at www.AngioDynamics.com.

**

Read Full Disclaimer at www.pennyomega.com/disclaimer

10.4.14 15:17, kommentieren

Nokia (NOK) and Microsoft (MSFT), Transaction for EUR 5.44B in Cash Expected to Close This Month, Th

http://pennyomega.com/img/penny_omega_logo.jpg

chartstockalert

http://pennyomega.com/img/nok.jpg Nokia Corporation (NOK)

On September 3, 2013, Microsoft Corporation and NOK reported that the Boards of Directors for both companies have decided to enter into a transaction whereby Microsoft will purchase substantially all of NOK's Devices & Services business, license NOK's patents, and license and use NOK's mapping services.

Under the terms of the agreement, Microsoft will pay EUR 3.79 billion to purchase substantially all of NOK's Devices & Services business, and EUR 1.65 billion to license NOK's patents, for a total transaction price of EUR 5.44 billion in cash.

NOK reported today that it has received regulatory approval from the Ministry of Commerce of the People's Republic of China.

The closing of the transaction is subject to regulatory approvals and other customary closing conditions. NOK and Microsoft have now received regulatory approvals from the People's Republic of China, the European Commission, the U.S. Department of Justice and numerous other jurisdictions.

NOK and Microsoft continue to expect the transaction to close during April 2014

http://pennyomega.com/img/nok_chart.png

NOK is a global leader in mobile communications whose products have become an integral part of the lives of people around the world.

More about Nokia Corporation (NOK) at www.nokia.com

**

http://pennyomega.com/img/crwe_logo.jpg Crown Equity Holdings Inc. (CRWE)

CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet.

CRWE is currently developing its CRWE Network (CRWE-PR.com), a social networking service compatible with both, the mobile and desktop web platform, that is designed to target all the communities in the U.S. and Canada.

Update: The CRWE Network, which business model is based on selling advertising to local businesses, has reached the 365th community website in the U.S., associated with 1680 ZIP Codes, and includes coverage of the greater state of California, Northern and Southern Nevada, Wellington in Florida and 9 provinces in Canada

http://pennyomega.com/img/crweapr8.jpg

CRWE Network’s goal is to facilitate exchanges of goods and services in a manner similar to Craigslist, a classified advertisements website with sections devoted to jobs, housing, personals, for sale, items wanted, services, community, gigs, résumés, and discussion forums, while providing micro community news, information and business directory content.

More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com

**

http://pennyomega.com/img/txmd.jpg TherapeuticsMD, Inc. (TXMD)

The North American Menopause Society (NAMS) estimates that up to 50% of postmenopausal women are affected by Vulvar and vaginal atrophy (VVA), which results from the decrease in estrogen that occurs with menopause. Symptoms include dyspareunia (pain with intercourse), vaginal dryness, and irritation and may affect sexual activities, relationships, and activities of daily life.

The U.S. Census estimates the number of postmenopausal women in the U.S. will exceed 50 million in 2015.

TXMD reported positive results of a rabbit irritation study for its TX 004-HR, a rapidly acting estrogen vaginal preparation capsule (VagiCap)

This toxicity study involved vaginal administration of VagiCap in New Zealand white female rabbits. The study demonstrated that TX 004-HR was "non-irritant" following a 28-day repeated application to the vaginal mucosa.

This toxicity study was conducted to meet a specific FDA requirement for any new component of a novel delivery system, such as the VagiCap vaginal softgel capsule for estradiol. Because the components of the VagiCap had not been previously studied in vaginal delivery, the capsule was required to pass this local toxicity assessment at repeated doses.

TX 004-HR estradiol VagiCap is an investigational drug enabling the vaginal administration of estradiol that is designed to treat moderate to severe VVA symptoms associated with menopause. TX 004-HR leverages the solubilized estradiol technology developed by TXMD in a unique, tear-shaped softgel capsule designed for easy intravaginal insertion.

** TXMD's TX 004-HR estradiol VagiCap is the first softgel capsule for the treatment of VVA being developed for review by the FDA **

Source Healthcare Analytics estimated the U.S. market for postmenopausal VVA was over $1 billion in 2013, increasing more than 20% over the prior year. GlobalData currently projects the global market for postmenopausal VVA will reach $3.1 billion by 2019.

http://pennyomega.com/img/txmd_chart.png

TXMD is a specialty pharmaceutical company focused on creating safe and effective branded prescription, generic prescription, and over-the-counter (non-prescription) products targeted exclusively for women.

More about TherapeuticsMD, Inc. (TXMD) at www.therapeuticsmd.com

**

Read Full Disclaimer at www.pennyomega.com/disclaimer

8.4.14 12:17, kommentieren

Cincinnati Bell (CBB) $210M Wireless Spectrum Licenses Sale, Achaogen (AKAO) Initiated with a Buy

http://pennyomega.com/img/penny_omega_logo.jpg

chartstockalert

http://pennyomega.com/img/cbb.jpg Cincinnati Bell Inc. (CBB)

CBB reported that it has entered into agreements to sell its wireless spectrum licenses and certain related assets to Verizon Wireless for cash and an assumption of certain Cincinnati Bell liabilities with a total value to CBB of approximately $210 million.

Cincinnati Bell Wireless will, for a nominal charge, lease back the spectrum it is selling for a period of time following the closing of the purchase transaction, during which it will wind down its wireless network operations and assist its wireless customers in transitioning their service arrangements to Verizon Wireless or other wireless providers.

The total value of the deal is estimated to be 4.5 and 6.0 times 2014 and 2015 Cincinnati Bell Wireless Adjusted EBITDA consensus wireless estimates respectively.

The purchase transaction is subject to customary closing conditions, including regulatory approval by the Federal Communications Commission.

http://pennyomega.com/img/cbb_chart.png

CBB provides integrated communications solutions including local and long distance voice, data, high-speed Internet, entertainment, and wireless services that keep residential and business customers in Greater Cincinnati and Dayton connected with each other and with the world.

More about Cincinnati Bell Inc. (CBB) at www.cincinnatibell.com.

**

http://pennyomega.com/img/crwe_logo.jpg Crown Equity Holdings Inc. (CRWE)

CRWE is currently developing its CRWE Network (CRWE-PR.com), a social networking service compatible with both, the mobile and desktop web platform, that is designed to target all the communities in the U.S. and Canada.

Update: The CRWE Network, which business model is based on selling advertising to local businesses, has reached the 355th community website in the U.S., associated with 1624 ZIP Codes, and includes coverage of the greater state of California, Northern and Southern Nevada, Wellington in Florida and 9 provinces in Canada

http://crwe-pr.com/wp-content/uploads/2013/12/CRWE_Network.jpg

CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet.

More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com

**

http://pennyomega.com/img/akao.jpg Achaogen, Inc. (AKAO)

AKAO was initiated with a Buy and a price target of $21.00 per share by brokerage firm Needham.

AKAO is developing plazomicin, its lead product candidate, for the treatment of serious bacterial infections due to multi-drug resistant (MDR) Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae.

http://pennyomega.com/img/akao_chart.png

AKAO is a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant (MDR) gram-negative infections

More about Achaogen, Inc. (AKAO) at www.achaogen.com

**

Read Full Disclaimer at www.pennyomega.com/disclaimer

7.4.14 14:51, kommentieren

Response Genetics (RGDX) Six New Provider Networks Contracts, Syneron Medical (ELOS) CE Mark for Str

http://pennyomega.com/img/penny_omega_logo.jpg

chartstockalert

http://pennyomega.com/img/rgdx.jpg Response Genetics, Inc. (RGDX)

RGDX reported that it has signed agreements with six additional health plans across 10 states bringing the Company's total national contracted membership to more than 174 million lives.

With these agreements, RGDX is now in-network with a total of thirteen Blue Cross Blue Shield health plans, which brings the total number of "Blues" subscribers with direct access to RGDX to approximately 23 million. Among RGDX's other Blue Cross Blue Shield contracts are Blue Cross and Blue Shield of Illinois, Blue Shield of California and CareFirst BlueCross BlueShield (Maryland, Washington, DC and Northern Virginia).

In addition to its recently launched proprietary ResponseDX: Tissue of Origin(TM) diagnostic test, RGDX's molecular testing primarily focuses on therapy-selection for patients with lung, colon, gastric, melanoma, and thyroid cancers.

RGDX's menu of genomic assays provides treating physicians actionable information on a patient's tumor by predicting which course of therapy will work best for that patient. In this way, RGDX's participation with these Blues plans should improve plan members' access to individually-tailored medicine.

http://pennyomega.com/img/rgdx_chart1.png

RGDX is a CLIA-certified clinical laboratory focused on the development and sale of molecular diagnostic testing services for cancer.

More about Response Genetics, Inc. (RGDX) at www.responsegenetics.com.

**

http://pennyomega.com/img/crwe_logo.jpg Crown Equity Holdings Inc. (CRWE)

CRWE provides marketing solutions that boost customer awareness and merchant visibility on the Internet.

CRWE is currently developing its CRWE Network (CRWE-PR.com), a social networking service compatible with both, the mobile and desktop web platform, that is designed to target all the communities in the U.S. and Canada.

Update: The CRWE Network, which business model is based on selling advertising to local businesses, has reached the 323th community website in the U.S., associated with 1535 ZIP Codes, and includes coverage of the greater state of California, Northern and Southern Nevada, Wellington in Florida and 9 provinces in Canada

http://pennyomega.com/img/crweapr3.jpg

CRWE‘s community targeted publications of websites will offer businesses’ owners the power of developing and publishing their own advertisement through the use of the CRWE Network’s platform to entice potential nearby consumers within its community with offers and deals. Advertisement on a national level is presently operational with local advertisement/coupon being available soon.

CRWE Network’s goal is to facilitate exchanges of goods and services in a manner similar to Craigslist, a classified advertisements website with sections devoted to jobs, housing, personals, for sale, items wanted, services, community, gigs, résumés, and discussion forums, while providing micro community news, information and business directory content.

More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com

**

http://pennyomega.com/img/elos.jpg Syneron Medical Ltd. (ELOS)

Stretch marks are one of the most common skin disorders, impacting 95% of women during puberty or pregnancy, and can also occur in men and children. Historically difficult to treat, striae occur when the skin is stretched from rapid growth or weight gain, and causes damage to the connective tissue in the dermis.

Acne is a common condition experienced by up to 85% of adolescents and young adults and 5% of older adults. In some patients, the healing process results in permanent, disfiguring scars. Treatments ranged from chemical peels to ablative procedures with long recovery times and risky side effects.

ELOS reported that its proprietary Sublative(TM) technology has received CE Mark indication for the effective treatment of striae (stretch marks) and acne scars.

ELOS' Sublative has been shown to be an effective and safe way to reduce the appearance of stretch marks, acne scars and other skin irregularities in all skin types with minimal side effects, discomfort or downtime.

The unique patented technology uses fractionated bi-polar radiofrequency directed to the skin in the form of a matrix. Due to its unique design, energy is deposited in the skin to initiate a healing response with minimal epidermal disruption. Patients benefit from a comfortable treatment with significant outcomes avoiding the potential complications of more aggressive treatments.

After treatment with ELOS' Sublative, the appearance of stretch marks and acne scars are greatly reduced.

http://pennyomega.com/img/elos_chart1.png

ELOS is a leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint.

More about Syneron Medical Ltd. (ELOS) at www.syneron.com

**

Read Full Disclaimer at www.pennyomega.com/disclaimer

3.4.14 14:42, kommentieren